Skip to content

Study · Measured the body's own peptide · 1984

3 results

Immunoreactive thymosin alpha 1 is associated with murine T-cell lymphomas.

Zatz MM, McClure JE, Goldstein AL

Leukemia research1 Jan 1984Cited by 3 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study3

No result from this study comes from a test of the peptide.

Natural levels measured3

These results measure the body's own peptide. Nobody was given the peptide. They are not evidence about taking it. They are left out of key results, evidence counts and charts.

  1. 01AnimalEndogenous levelAnimal study (in vivo)Other

    In AKR mice, growth of spontaneous and transplanted T-cell lymphomas was associated with marked elevations of serum immunoreactive thymosin alpha‑1.

    In plain wordsIn mice with T-cell lymphoma, the body's own thymosin alpha‑1 in blood was much higher.

    Outcome
    IncreaseSerum immunoreactive thymosin alpha 1 with T-cell lymphoma growth
    Study

    mousen: not reported in source

    AKR mice with spontaneous or transplanted T-cell lymphomas
    Outcome group
    Immune response · Cancer

    Source sentences

    Summary
    Growth of murine spontaneous and transplanted AKR T-cell lymphomas results in marked elevations of serum immunoreactive thymosin alpha 1.

    This result measures the body's own Thymosin alpha-1. Nobody was given the peptide. It is not evidence about taking it.

  2. 02AnimalEndogenous levelAnimal study (in vivo)Other

    In mice, growth of a B-cell lymphoma did not raise serum immunoreactive thymosin alpha‑1.

    In plain wordsIn mice with B-cell lymphoma, the body's own thymosin alpha‑1 in blood did not rise.

    Outcome
    No significant changeSerum immunoreactive thymosin alpha 1 with B-cell lymphoma growth
    Study

    mousen: not reported in source

    AKR mice with spontaneous or transplanted T-cell lymphomas
    Outcome group
    Immune response · Cancer

    Source sentences

    Summary
    Growth of a B-cell lymphoma does not generate elevated immunoreactive thymosin alpha 1 in the serum, thus, a thymosin alpha 1-like peptide is selectively associated with these T-cell lymphomas.

    This result measures the body's own Thymosin alpha-1. Nobody was given the peptide. It is not evidence about taking it.

  3. 03AnimalEndogenous levelAnimal study (in vivo)Mechanism

    In mice with T-cell lymphomas, the elevation of serum thymosin alpha‑1 was not mediated by the thymus and seemed to be directly associated with the tumor cells.

    In plain wordsIn mice, the rise in the body's own thymosin alpha‑1 seemed linked to the tumor cells, not to the thymus.

    Outcome
    Not applicableSource of the elevated serum thymosin alpha 1
    Study

    mousen: not reported in source

    AKR mice with spontaneous or transplanted T-cell lymphomas
    Outcome group
    Immune response · Cancer

    Source sentences

    Summary
    This elevation, however, is not mediated by the thymus but rather, seems to be directly associated with the tumor cells.

    This result measures the body's own Thymosin alpha-1. Nobody was given the peptide. It is not evidence about taking it.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 3Current

    10 Oct 2026, 08:55 UTC

    Study results updated

  2. Version 2

    9 Oct 2026, 03:03 UTC

    Study data updated · source update from Europe PMC

  3. Version 1

    9 Oct 2026, 03:02 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.